These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 14520940
1. [Indices of the lipid peroxidation--antioxidant defense system as markers of chronic cardiac failure in cardiomyopathies]. Volchegorskiĭ IA, Shaposhnik II, Alekseev EN, Kharchenkova NV. Klin Med (Mosk); 2003; 81(8):26-8. PubMed ID: 14520940 [Abstract] [Full Text] [Related]
2. [The condition of the antioxidant system and lipid peroxidation in victims with a severe compound trauma]. Kartavenko VI, Golikov PP, Davydov BV, Andreev AA. Patol Fiziol Eksp Ter; 2004; (1):8-10. PubMed ID: 15052868 [Abstract] [Full Text] [Related]
3. [Lipid peroxidation in patients with chronic heart failure]. Rudyk BI, Sabadyshin RA, Blinova NG. Ter Arkh; 1991; 63(12):66-9. PubMed ID: 1803606 [No Abstract] [Full Text] [Related]
4. [Levels of lipid peroxidation products and ceruloplasmin in blood as characteristics of tolerance to physical load in hypertrophic cardiomyopathy]. Volchegorskiĭ IA, Shaposhnik II, Alekseev EN, Kharchenkova NV. Klin Lab Diagn; 2002 Feb; (2):11-3. PubMed ID: 11899520 [Abstract] [Full Text] [Related]
5. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. Boffa GM, Zaninotto M, Nalli C, Forni M, Tiso E, Razzolini R, Plebani M. Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581 [Abstract] [Full Text] [Related]
6. Exercise-induced increase in lipid peroxidation in patients with chronic heart failure: relation to exercise intolerance. Sayar N, Terzi S, Yilmaz HY, Tangurek B, Bilsel T, Cakmak N, Orhan L, Emre A, Ciloglu F, Peker I, Yesilcimen K. Cardiology; 2007 Jan; 108(4):307-13. PubMed ID: 17290101 [Abstract] [Full Text] [Related]
7. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Llurba E, Gratacós E, Martín-Gallán P, Cabero L, Dominguez C. Free Radic Biol Med; 2004 Aug 15; 37(4):557-70. PubMed ID: 15256227 [Abstract] [Full Text] [Related]
8. Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure? Meyer T, Schwaab B, Görge G, Scharhag J, Herrmann M, Kindermann W. Z Kardiol; 2004 Jul 15; 93(7):540-5. PubMed ID: 15243765 [Abstract] [Full Text] [Related]
9. Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. Ripa S, Ripa R, Giustiniani S. Minerva Med; 1998 Jul 15; 89(11-12):397-403. PubMed ID: 10212663 [Abstract] [Full Text] [Related]
10. [Characteristics of autoimmune reactions in chronic cardiac failure of different etiology]. Zykov KA, Tatenkulova SN, Masenko VP, Kuznetsova TV, Rvacheva AV, Belenkov IuN. Ter Arkh; 2009 Jul 15; 81(4):22-8. PubMed ID: 19514417 [Abstract] [Full Text] [Related]
11. [Lipid peroxidation and antioxidant systems in patients with HIV infection]. Nagoev BS, Sabanchieva ZhKh. Ter Arkh; 2007 Jul 15; 79(12):70-2. PubMed ID: 18220037 [Abstract] [Full Text] [Related]
12. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy. Athanassopoulos P, Balk AH, Vaessen LM, Caliskan K, Takkenberg JJ, Weimar W, Bogers AJ. Int J Cardiol; 2009 Jan 09; 131(2):246-56. PubMed ID: 18243370 [Abstract] [Full Text] [Related]
13. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy. Bredin F, Liska J, Franco-Cereceda A. Interact Cardiovasc Thorac Surg; 2009 Feb 09; 8(2):191-4. PubMed ID: 19008326 [Abstract] [Full Text] [Related]
14. Dehydroepiandrosterone levels vary according as heart failure condition in patients with idiopathic dilated cardiomyopathy. Kawano H, Nagayoshi Y, Soejima H, Tanaka Y, Yamabe H, Kinoshita Y, Ogawa H. Int J Cardiol; 2008 Apr 10; 125(2):277-9. PubMed ID: 18234363 [Abstract] [Full Text] [Related]
15. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. Högye M, Mándi Y, Csanády M, Sepp R, Buzás K. Am J Cardiol; 2004 Jul 15; 94(2):249-51. PubMed ID: 15246916 [Abstract] [Full Text] [Related]
16. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Skwarek M, Bilińska ZT, Mazurkiewicz Ł, Grzybowski J, Kruk M, Kurjata P, Piotrowski W, Ruzyłło W. Kardiol Pol; 2008 May 15; 66(5):515-22, discussion 523-4. PubMed ID: 18537059 [Abstract] [Full Text] [Related]
17. Blood glutathione as independent marker of lipid peroxidation in heart failure. Campolo J, De Maria R, Caruso R, Accinni R, Turazza F, Parolini M, Roubina E, De Chiara B, Cighetti G, Frigerio M, Vitali E, Parodi O. Int J Cardiol; 2007 Apr 12; 117(1):45-50. PubMed ID: 16884794 [Abstract] [Full Text] [Related]
18. [Clinicoimmunological disorders in patients with postinfarction left ventricular remodeling and chronic cardiac failure]. Teplliakov AT, Bolotskaia LA, Dibirov MM, Stepacheva TA, Karaman NV, Vdovina TV, Shilov SN, Kuznetsova AV. Ter Arkh; 2008 Apr 12; 80(11):52-7. PubMed ID: 19143193 [Abstract] [Full Text] [Related]
19. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus. Peerapatdit T, Likidlilid A, Patchanans N, Somkasetrin A. J Med Assoc Thai; 2006 Nov 12; 89 Suppl 5():S141-6. PubMed ID: 17718255 [Abstract] [Full Text] [Related]
20. Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy. Pascual-Figal DA, Peñafiel P, de la Morena G, Redondo B, Nicolás F, Casas T, Valdés M. Am J Cardiol; 2007 May 01; 99(9):1279-83. PubMed ID: 17478157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]